AeroLeads people directory · profile
Rick L. Email & Phone Number
President and CEO
at
Eikonizo Therapeutics
1 work email found
@eikonizo.com
6 phones found area 617, 857, and 781
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
President and CEO
Location
Lexington, Massachusetts, United States
Company size
Who is Rick L.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Rick L. is listed as President and CEO at Eikonizo Therapeutics, a company with 14 employees, based in Lexington, Massachusetts, United States. AeroLeads shows a work email signal at eikonizo.com, phone signal with area code 617, 857, 781, and a matched LinkedIn profile for Rick L..
Rick L. previously worked as President & CEO at Eikonizo Therapeutics and President at 7S Bioventures. Rick L. holds Bs, Biochemical Sciences from Harvard University.
Company email context
Email format at Eikonizo Therapeutics
This section adds company-level context without repeating Rick L.'s masked contact details.
*@eikonizo.com
71% confidence
AeroLeads found 1 current-domain work email signal for Rick L.. Compare company email patterns before reaching out.
Profile bio
About Rick L.
Results-focused biopharma entrepreneur with 30+ years of early-stage company-building experience and a successful track record developing strategic business plans, raising capital, and creating value through team building, operational excellence and strategic partnerships and M&A. Navitor Pharma founding team member with overall responsibility for strategy, corporate and business development, finance, operations and legal/administration. Raised over $100M in equity capital and closed partnering transactions with total potential value of nearly $1B.Prior to joining Navitor, founded 7S BioVentures, providing strategy, deal-making and executional leadership to established and emerging Life Sciences companies and investors. From 2006 to 2009, responsible for ex-U.S. commercial strategy and business development at Targanta Therapeutics (acquired by The Medicines Company). Previously, led therapeutics business development initiatives and managed the genomics services business at Celera Genomics. Before that, nearly a decade at Biogen in a broad range of business roles, including business development, program management, investor relations, sales and marketing.BA in Biochemical Sciences from Harvard University.
Listed skills include Lifesciences, Drug Development, Pharmaceutical Industry, Biopharmaceuticals, and 34 others.
Current workplace
Rick L.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Eikonizo Therapeutics
8 roles · 39 years
Rick L. work experience
A career timeline built from the work history available for this profile.
President & Ceo
CurrentEikonizo is developing highly selective, brain-penetrant small molecule histone deacetylase 6 (HDAC6) inhibitors as disease-modifying therapeutics for neurodegenerative disease, including amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy (CIPN) and Alzheimer’s disease as well as peripherally-restricted HDAC6 inhibitors for.
Aug 2022 - Present
President
Current
7S Bioventures
- Providing strategy, deal-making and executional leadership to established and emerging Life Sciences companies and investors. Projects have included:
- Closed seed financing for Polaris-incubated NewCo (now Navitor); led creation of initial business plan and joined company full-time after closing Series A.
- Start-Up CEO role for seed-stage venture developing novel protein therapeutics for the treatment and repair of ischemic injury.
- Led BD efforts for venture-backed company developing an unique infusion system for SC delivery of high volume/viscosity drugs based on MIT scientific founder's IP.
- Led creation and execution of strategy to partner company’s lead antibiotic compounds and other compounds derived from technology platform.
- Led creation of initial business plan for a venture-incubated NewCo based on Harvard scientific founder's IP.
2005 - Present
~21 yrs 5 mos
Svp, Corporate Development; Secretary And Treasurer
Founding team member with overall responsibility for strategy, corporate and business development, finance, operations and legal/administration. Raised over $100M in equity capital and closed partnering transactions with total potential payments of nearly $1B including: Development and Option Agreement with Supernus Pharma (NV-5138 for TRD), and; spin-off.
Sep 2013 - Mar 2022
Director, Business Development
Reporting to CEO, led strategy development and execution, including primary negotiating responsibility, for ex-US partnerships for oritavancin, Targanta’s antibiotic for serious gram positive infections including MRSA.Targanta was acquired by The Medicines Company in Feb '09 and ORBACTIV®(oritavancin) was approved in the US in Aug'14 and EU in Mar'15.
Nov 2006 - Feb 2009
Various Positions
Led creation and implementation of Celera’s initial biopharma collaborative partnering strategy to leverage Celera's knowledge of the human genome in drug development. Provided business development and strategy support for Celera’s proteomics target discovery, oncology and virology programs. P&L responsibility for Celera’s contract services business.
2000 - 2004
~4 yrs
Various Positions
Broad range of business roles including business development, program management, investor relations, sales and marketing.
1990 - 2000
~10 yrs
Research Technician
Remold-O'Donnell Lab, Center for Blood Research. Characterized novel serine protease inhibitors.
1987 - 1989
~2 yrs
1 education record
Rick L. education
-
Harvard University
FAQ
Frequently asked questions about Rick L.
Quick answers generated from the profile data available on this page.
What company does Rick L. work for?
Rick L. works for Eikonizo Therapeutics.
What is Rick L.'s role at Eikonizo Therapeutics?
Rick L. is listed as President and CEO at Eikonizo Therapeutics.
What is Rick L.'s email address?
AeroLeads has found 1 work email signal at @eikonizo.com for Rick L. at Eikonizo Therapeutics.
What is Rick L.'s phone number?
AeroLeads has found 6 phone signal(s) with area code 617, 857, 781 for Rick L. at Eikonizo Therapeutics.
Where is Rick L. based?
Rick L. is based in Lexington, Massachusetts, United States while working with Eikonizo Therapeutics.
What companies has Rick L. worked for?
Rick L. has worked for Eikonizo Therapeutics, 7S Bioventures, Navitor Pharmaceuticals, Targanta Therapeutics, and Celera Genomics.
Who are Rick L.'s colleagues at Eikonizo Therapeutics?
Rick L.'s colleagues at Eikonizo Therapeutics include Rebecca James (She/Her), Ph.D. and Lauren Evans.
How can I contact Rick L.?
You can use AeroLeads to view verified contact signals for Rick L. at Eikonizo Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Rick L. attend?
Rick L. holds Bs, Biochemical Sciences from Harvard University.
What skills is Rick L. known for?
Rick L. is listed with skills including Lifesciences, Drug Development, Pharmaceutical Industry, Biopharmaceuticals, Life Sciences, Biotechnology, Business Development, and Strategic Alliances.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial